Awiqli, also known as insulin icodec, is a once-weekly basal insulin approved for adults with type 2 diabetes. It may help reduce the burden of daily insulin injections while supporting A1c reduction, but careful dosing and patient education are essential.

More than 350 cases of Lyme disease, Delaware’s most common tick-borne disease, were reported in 2025, reinforcing why tick prevention matters across the state.

More than 200 cases of alpha-gal syndrome have been reported in Delaware since it became reportable in 2024, making tick prevention more important for residents and visitors.